World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
104
Citations
47383
World Ranking
6975
National Ranking
3669

Overview

Gil D. Rabinovici is affiliated with the University of California, San Francisco in the United States. Their research primarily focuses on the field of Medicine with significant contributions in Psychiatry and Mental Health, Physiology, Cognitive Neuroscience, Radiology, Nuclear Medicine and Imaging, and Neurology.

The scientist's work encompasses several main topics, including:

  • Dementia and Cognitive Impairment Research
  • Alzheimer's disease research and treatments
  • Functional Brain Connectivity Studies
  • Advanced Neuroimaging Techniques and Applications
  • Medical Imaging Techniques and Applications
  • Health Systems, Economic Evaluations, Quality of Life
  • Parkinson's Disease Mechanisms and Treatments

Recent papers authored or co-authored by Gil D. Rabinovici cover a range of medical and neurological topics. Notable publications include:

  • Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group, 2021, The Lancet Neurology
  • Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration, 2020, Nature Medicine
  • Four distinct trajectories of tau deposition identified in Alzheimer's disease, 2021, Nature Medicine
  • New insights into atypical Alzheimer's disease in the era of biomarkers, 2021, The Lancet Neurology
  • Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET, 2020, Science Translational Medicine

Gil D. Rabinovici frequently collaborates with other researchers. Frequent co-authors include:

  • Renaud La Joie
  • Bruce L. Miller
  • Joel H. Kramer
  • María C. Carrillo
  • Leonardo Iaccarino

The scientist has published extensively in several venues, which include:

  • Alzheimer s & Dementia
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Neurology
  • JAMA Neurology
  • Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring

Best Publications

  • Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

    Bruno Dubois;Bruno Dubois;Howard H Feldman;Claudia Jacova;Harald Hampel;Harald Hampel

  • Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria

    Günter U Höglinger;Gesine Respondek;Maria Stamelou;Carolin Kurz

  • Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.

    Bruno Dubois;Harald Hampel;Harald Hampel;Howard H. Feldman;Philip Scheltens

  • Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

    Sandip Ray;Markus Britschgi;Charles Herbert;Yoshiko Takeda-Uchimura

  • PET Imaging of Tau Deposition in the Aging Human Brain

    Michael Schöll;Michael Schöll;Samuel N. Lockhart;Daniel R. Schonhaut;James P. O’Neil

  • Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.

    Rik Ossenkoppele;Rik Ossenkoppele;Rik Ossenkoppele;Daniel R. Schonhaut;Daniel R. Schonhaut;Michael Schöll;Michael Schöll;Samuel N. Lockhart

  • Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease

    Juan Zhou;Michael D. Greicius;Efstathios D. Gennatas;Matthew E. Growdon

  • Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group.

    Bruno Dubois;Nicolas Villain;Giovanni B. Frisoni;Gil D. Rabinovici

  • Episodic memory loss is related to hippocampal-mediated -amyloid deposition in elderly subjects

    E. C. Mormino;J. T. Kluth;C. M. Madison;G. D. Rabinovici;G. D. Rabinovici;G. D. Rabinovici

  • Seizures and Epileptiform Activity in the Early Stages of Alzheimer Disease

    Keith A. Vossel;Alexander J. Beagle;Gil D. Rabinovici;Huidy Shu;Huidy Shu

  • Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease.

    Alexandre Bejanin;Daniel R Schonhaut;Renaud La Joie;Joel H Kramer

  • Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration.

    Elisabeth H. Thijssen;Elisabeth H. Thijssen;Renaud La Joie;Amy Wolf;Amelia Strom

  • Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.

    Rik Ossenkoppele;Willemijn J Jansen;Gil D Rabinovici;Dirk L Knol

  • Four distinct trajectories of tau deposition identified in Alzheimer’s disease

    Jacob W Vogel;Alexandra L Young;Neil P Oxtoby;Ruben Smith

  • Posterior cortical atrophy

    Sebastian J Crutch;Manja Lehmann;Manja Lehmann;Jonathan M Schott;Gil D Rabinovici

  • Consensus classification of posterior cortical atrophy

    Sebastian J. Crutch;Jonathan M. Schott;Gil D. Rabinovici;Melissa Murray

  • Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management.

    Gil D. Rabinovici;Bruce L. Miller

  • The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.

    Rik Ossenkoppele;Yolande A. L. Pijnenburg;David C. Perry;Brendan I. Cohn-Sheehy

  • Aβ amyloid and glucose metabolism in three variants of primary progressive aphasia

    Gil D Rabinovici;William J Jagust;Ansgar J Furst;Ansgar J Furst;Jennifer M Ogar;Jennifer M Ogar

  • Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia.

    Gil D. Rabinovici;Constantine Gatsonis;Charles Apgar;Kiran Chaudhary

Frequent Co-Authors

Bruce L. Miller
Bruce L. Miller University of California, San Francisco
William J. Jagust
William J. Jagust University of California, Berkeley
Rik Ossenkoppele
Rik Ossenkoppele Lund University
Howard J. Rosen
Howard J. Rosen University of California, San Francisco
William W. Seeley
William W. Seeley University of California, San Francisco
Renaud La Joie
Renaud La Joie University of California, San Francisco
Joel H. Kramer
Joel H. Kramer University of California, San Francisco
Suzanne L. Baker
Suzanne L. Baker Lawrence Berkeley National Laboratory
Lea T. Grinberg
Lea T. Grinberg University of California, San Francisco
Maria Luisa Gorno-Tempini
Maria Luisa Gorno-Tempini University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in studying medicine or expanding your healthcare career in the USA, online degrees offer flexible options. Many prospective students seek which online healthcare degree programs are recognized for their accreditation by cahme? Accreditation from CAHME is important, as it ensures a high-quality curriculum for healthcare administration programs.

For registered nurses, rn bsn online programs no clinicals are a convenient way to advance one’s qualifications while balancing work and other responsibilities. These programs enable nurses to earn a bachelor’s degree without the need for on-site clinical rotations.

Those who aspire to reach the highest levels of nursing leadership may consider the shortest dnp program online for a fast-track path, or look for the cheapest dnp program to minimize financial burden. These Doctor of Nursing Practice programs are designed to meet workforce demand for advanced practitioners and leaders.

Overall, online healthcare education in the USA offers diverse pathways for both clinical and non-clinical roles, tailored to meet different schedules and career ambitions.

Best Scientists Citing Gil D. Rabinovici

Trending Scientists